Home|About This Site|About Us|Maps & Parking|Giving|Contact Us|Careers|Med-U-Nurse
Medical University Hospital home page
Center for Drug & Alcohol Programs
Search:

About the Center for Drug & Alcohol Programs

Faculty

Clinical Services
Clinical Trials
Research
Seminars
Grand Rounds
Journal Clubs
Training
Conferences
Addiction Information
Podcast Library
Video Library
Giving
Contact Us
Quick Clicks
>2005-2006 Annual Report
>2004-2005 Annual Report
>2003-2004 Annual Report
>Charleston Alcohol Research Center
>Department of Psychiatry & Behavioral Sciences
>National Institute on Alcohol Abuse and Alcoholism
>National Institute on Drug Abuse
>Research Society on Alcoholism
>Alcohol Beverage Medical Research Foundation (ABMRF)
>Clinical Neurobiology Laboratory/%CDT Testing


Patients and Visitors
Medical Services
Health Information
Community Events
Health Professionals
Home > CDAP > Dr. Raymond Anton
Dr. Raymond Anton

email icon

printer icon

print

Distinguished University Professor   
Professor, Department of Psychiatry and Behavioral Sciences
Director, Center for Drug & Alcohol Programs
Director, Clinical Neurobiology Laboratories

EDUCATION

Rutgers College, New Brunswick, NJ    B.A.     1972     Biosciences
Rutgers School of Medicine, New Brunswick, NJ    M.D.1976Medicine
Greenwich Hospital, Greenwich, CTInternship  1977Medicine
Yale New Haven Hospital & Connecticut Mental Health Center, New Haven, CTResidency1980Psychiatry
Yale University School of Medicine, New Haven, CTPostdoctoral   1980Psychiatry

PROFESSIONAL EXPERIENCE

1980-1985Assistant Professor, Department of Psychiatry & Behavioral Sciences, MUSC, Charleston, SC
1980-1988Staff Psychiatrist, Ralph H. Johnson Veterans Affairs Medical Center, Charleston, SC
1984-1988Director, Psychopharmacology Research, Veterans Affairs Medical Center, Charleston, SC
1985-1991Associate Professor, Department of Psychiatry & Behavioral Sciences, MUSC, Charleston, SC
1988-presentDirector, Clinical-Neurobiology Laboratories, Department of Psychiatry & Behavioral Sciences, MUSC, Charleston, SC
1991-presentProfessor, Department of Psychiatry & Behavioral Sciences, MUSC, Charleston, SC
1993-2001Director, Alcohol Medication Studies, Center for Drug and Alcohol Programs, MUSC, Charleston, SC
1995-presentScientific Director for Clinical Research, Charleston Alcohol Research Center, MUSC, Charleston, SC
2001-presentDirector, Center for Drug and Alcohol Programs, MUSC, Charleston, SC
2002-presentDistinguished University Professor, MUSC, Charleston, SC

AWARDS AND HONORS

1991NIAAA Alcohol Psychosocial Research Review Committee (Member Clinical & Treatment Subcommittee; Chair, 1993-1994)
1992NIAAA Working Group on Methodology in Clinical Treatment Research Trials
1992NIAAA Task Force on Revision of the Treatment Assessment Manual
1996American College of Neuropsychopharmacology (elected member)
1997American Society of Addiction Medicine (diplomat)
1997Added Qualifications in Addiction Psychiatry
1999Board of Directors, Research Society on Alcoholism
1999-2002Board of Scientific Counselors of the National Institute of Alcohol Abuse and Alcoholism
2000-presentMember, Board of reviewing Editors, Alcoholism: Clinical and Experimental Research
2000-presentChairman, Steering Committee, COMBINE Study
2001Treasurer, Research Society on Alcoholism
2003American College of Neuropsychopharmacology (elected fellow)
2005Vice-Chairman, Board of Trustees, Alcohol Beverage Medical Research Foundation
2007-presentPresident, Research Society on Alcoholism
2008Distinguished Fellow, American Psychiatric Association


PUBLICATIONS (2006-present)
Anton RF, Miller WR, O'Malley SS, Zweben A & Hosking JD. Pharmacotherapy and behavioral intervention for alcohol dependence-Reply. Journal of the American Medical Association 296(14):1728-1729, 2006.

Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, Randall CL, Swift R, Weiss RD, Williams LD, Zweben A & Combine Study Research Group. Combined pharmacotherapies and behavioral interventions for alcohol dependence: The COMBINE study: A randomized controlled trial. Journal of the American Medical Association 295(17):2003-2017, 2006.

Anton RF & Youngblood M. Factors affecting %CDT status at entry into a multisite clinical treatment trial: Experience from the COMBINE study. Alcoholism: Clinical & Experimental Research 30(11):1878-1883, 2006.

Brady KT, Back SE, Waldrop AE, McRae AL, Anton RF, Upadhyaya HP, Saladin ME & Randall PK. Cold pressor task reactivity: Predictors of alcohol use among alcohol-dependent individuals with and without comorbid posttraumatic stress disorder. Alcoholism: Clinical & Experimental Research 30(6):938-946, 2006.

Brady KT, Waldrop AE, McRae AL, Back SE, Saladin ME, Upadhyaya HP, Anton RF & Randall PK. The impact of alcohol dependence and posttraumatic stress disorder on cold pressor task response. Journal of Studies on Alcohol 67(5):700-706, 2006.

Miller PM, Spies C, Neumann T, Javors MA, Hoyumpa AM, Roache J, Webb A, Kashi M, Sharkey FE, Anton RF, Egan BM, Basile J, Nguyen S, Fleming MF & Dillie KS. Alcohol biomarker screening in medical and surgical settings. Alcoholism: Clinical and Experimental Research 30(2):185-193, 2006.

Work Group on Substance Use Disorders (Anton RF) & American Psychiatric Association Steering Committee on Practice Guidelines. Treatment of patients with substance use disorders, Second Edition. American Psychiatric Association. American Journal of Psychiatry 163(8 Suppl):5-82, 2006.

Baros AM, Latham PK, Moak DH, Voronin K & Anton RF. What role does measuring medication compliance play in evaluating the efficacy of naltrexone? Alcoholism: Clinical & Experimental Research 31(4):596-603, 2007.

Cluver JS, Miller PM & Anton RF. Case studies of the utility of serum carbohydrate-deficient transferrin (%CDT) in the clinical management of alcoholics. Journal of Addiction Medicine 1(1):44-47, 2007.

Jeppsson J-O, Arndt T, Schellenberg F, Wielders JPM, Anton RF, Whitfield JB, Helander A & International Federation of Clinical Chemistry and Laboratory Medicine Working Group on Standardization of Carbohydrate-Deficient Transferin. Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: I. Analyte definition and proposal of a candidate reference method. Clinical Chemistry & Laboratory Medicine 45(4):558-562, 2007.

Myrick H, Anton RF, Voronin K, Wang W & Henderson S. A double blind evaluation of gabapentin on alcohol effects and drinking in a clinical laboratory paradigm. Alcoholism: Clinical & Experimental Research 31(2):221-227, 2007.

Work Group on Substance Use Disorders (Anton RF). Practice guideline for the treatment of patients with substance use disorders. Supplement to American Journal of Psychiatry 164(4):A5-124, 2007.

Wright TM, Baros AM & Anton RF. Pharmacotherapies for the Treatment of Alcohol Dependence: Current and on the Horizon In Translation of Addictions Science into Practice: Update and Future Directions, Miller PM, Kavanagh D (Eds). Elsevier-Pergamon, New York, NY, 2007.

Wright TM, Myrick H, Malcolm R, Randall P, Boyle E, Henderson S & Anton R. Impact of lifetime alcohol quit attempts and medicated detoxifications on time to relapse during an index alcohol detoxification. Journal of Addiction Medicine 1(1):15-20, 2007.

Page last updated: 01/14/2008
privacy statements | 

disclaimer

 | accessibility |  press room |  find a doctor | site map | e-newsletters
© 2008 Medical University of South Carolina
Health on the Net Foundation sealWe subscribe to the
HONcode Principles
Verify Here